Corticosteroids in brain cancer patients: benefits and pitfalls

Expert Review of Clinical Pharmacology
Jörg DietrichSantosh Kesari


Glucocorticoids have been used for decades in the treatment of brain tumor patients and belong to the most powerful class of agents in reducing tumor-associated edema and minimizing side effects and the risk of encephalopathy in patients undergoing radiation therapy. Unfortunately, corticosteroids are associated with numerous and well-characterized adverse effects, constituting a major challenge in patients requiring long-term application of corticosteroids. Novel antiangiogenic agents, such as bevacizumab (Avastin®), which have been increasingly used in cancer patients, are associated with significant steroid-sparing effects, allowing neuro-oncologists to reduce the overall use of corticosteroids in patients with progressive malignant brain tumors. Recent experimental studies have revealed novel insights into the mechanisms and effects of corticosteroids in cancer patients, including modulation of tumor biology, angiogenesis and steroid-associated neurotoxicity. This article summarizes current concepts of using corticosteroids in brain cancer patients and highlights potential pitfalls in their effects on both tumor and neural progenitor cells.


Oct 3, 2013·Journal of Neuro-oncology·Justyna KmiecikMartha Chekenya
Apr 10, 2014·PloS One·Zheng FanNicolai E Savaskan
Nov 19, 2014·CNS Drugs·Riccardo SoffiettiRoberta Rudà
Sep 23, 2014·The Veterinary Clinics of North America. Small Animal Practice·Nicholas D Jeffery
Jan 8, 2014·Ocular Immunology and Inflammation·Veronique B D KitiratschkyPeter Szurman
Jul 16, 2015·British Journal of Neurosurgery·Soumya MukherjeeRichard Gullan
Sep 28, 2015·Cancer Treatment Reviews·S D'OronzoF Silvestris
Aug 19, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qunya OngMichael J Cima
Mar 24, 2016·ACS Chemical Neuroscience·Erika L VarnerAdrian Charles Michael
Sep 4, 2015·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Sebastian AdebergJuergen Debus
Apr 30, 2015·Practical Neurology·Jan BittarIvo W Tremont-Lukats
Jan 23, 2013·Neurological Research·Ezequiel GoldschmidtPablo Argibay
Jan 30, 2016·Hospital Pharmacy·Matthew R RutledgeDominic A Solimando
Dec 23, 2015·Annals of Neurology·Ivana VodopivecJohn H Stone
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
Jun 16, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Nima AlanRobert J Weil
Jan 28, 2015·Neoplasia : an International Journal for Oncology Research·Maxim A ShevtsovAlexander M Ischenko
Dec 3, 2014·Archives of Medical Research·Serge C Thal, Winfried Neuhaus
Apr 29, 2016·British Journal of Anaesthesia·J LiL Meng
May 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Sayuri YoshihamaKoichi S Kobayashi
Nov 8, 2015·The Lancet Oncology·Hideho OkadaDavid A Reardon
Aug 18, 2016·Neuro-oncology·Eudocia Q Lee, Patrick Y Wen
Sep 11, 2016·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Roger Murayi, Prashant Chittiboina
Mar 8, 2016·Clinical Endocrinology·Sarah CatfordRosemary Wong
Jan 7, 2017·Journal of Neurosurgery·Martin PiazzaPrashant Chittiboina
Jul 9, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ornulf PaulsenStein Kaasa
Feb 1, 2017·Current Neurology and Neuroscience Reports·K Ina Ly, Patrick Y Wen
Feb 13, 2016·Revista brasileira de enfermagem·Kênia Cristina Soares Fonseca de MagalhãesKarla Rona da Silva
Apr 28, 2017·Journal of Veterinary Emergency and Critical Care·Maya A AharonKate Buriko
Mar 28, 2017·Biomolecules·A G M MostofaKalkunte S Srivenugopal
Sep 21, 2017·Medicine and Science in Sports and Exercise·Stéphane BaudryMarco A Minetto
Dec 26, 2015·Journal of Intensive Care Medicine·Andrew L Lin, Edward K Avila
May 18, 2018·Neuro-oncology·Nivedita M RatnamAmber J Giles
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Jan Drappatz
Aug 24, 2018·Clinical and Experimental Pharmacology & Physiology·Hiroyasu SakaiJunzo Kamei


Feb 26, 1976·The New England Journal of Medicine·H O Conn, B L Blitzer
Sep 1, 1977·Neurosurgery·J D MillerD P Becker
Feb 1, 1979·Annals of Internal Medicine·J K Penry, M E Newmark
Feb 12, 1992·JAMA : the Journal of the American Medical Association·K A SepkowitzD Armstrong
Aug 1, 1991·Neurology·E J Dropcho, S J Soong
Sep 1, 1991·The American Journal of Medicine·J L CarsonE Sim
Apr 1, 1991·Archives of Neurology·J W HensonA O Fels
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Sep 1, 1988·Journal of Neuro-oncology·N A Vick
Apr 1, 1986·Annals of Neurology·E Tessa Hedley-Whyte, D W Hsu
Jan 1, 1985·Journal of Chronic Diseases·H O Conn, T Poynard
Dec 1, 1974·Archives of Neurology·C L KoskiS R Max
Jan 1, 1972·The Journal of Clinical Endocrinology and Metabolism·N HaqueL J Sholiton
Oct 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·J B ChalkM J Eadie
Feb 1, 1995·Anti-cancer Drugs·P J Koehler
May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A Villalona-CaleroD D Von Hoff
Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·K LamszusE M Rosen
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D FranchimontJ J O'Shea
Apr 13, 2000·Journal of the International Neuropsychological Society : JINS·H ForgetH Cohen
Mar 14, 2001·Journal of Neuro-oncology·M R Machein, K H Plate
Jun 2, 2001·Journal of Neuro-oncology·B KaupM M Knüpfer
Jul 13, 2002·Annals of the New York Academy of Sciences·Costantino PitzalisMauro Perretti
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Marcel J M Schaaf, John A Cidlowski
Apr 3, 2003·Cancer Treatment Reviews·Beela S Mathew, Stuart A Grossman
Apr 20, 1957·Journal of the American Medical Association·S KOFMANS G TAYLOR
Dec 25, 2003·Journal of Clinical Pathology·N NathooM Golubic
Apr 10, 1952·The New England Journal of Medicine·F D INGRAHAMR L McLAURIN
Apr 6, 2004·Biochemical and Biophysical Research Communications·In Tag YuHyeon Son
Nov 25, 2004·Neuroscience·M C PapadopoulosA S Verkman
Jun 15, 2005·Expert Opinion on Biological Therapy·Allan Lipton
Aug 2, 2005·Immunology and Allergy Clinics of North America·Peter J Barnes
Nov 30, 2005·Cellular and Molecular Life Sciences : CMLS·M J HeroldH M Reichardt
May 19, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Maria SundbergDan Lindholm

Related Concepts

Corticosteroid-Binding Globulin Deficiency
Glucocorticoid inhalants for obstructive airway disease
Angiogenic Process
Tumor Angiogenesis
Corticosteroids, topical for treatment of hemorrhoids and anal fissures
Glucocorticoids, Systemic
Adverse Effects
Adrenal Cortex Hormones

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.